{"created":"2023-05-15T09:07:03.896297+00:00","id":14293,"links":{},"metadata":{"_buckets":{"deposit":"d92b56ab-28f7-4767-8370-a024b9550b93"},"_deposit":{"created_by":15,"id":"14293","owners":[15],"pid":{"revision_id":0,"type":"depid","value":"14293"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00014293","sets":["1658:1661:1716"]},"author_link":["24103","24104","24105","24106","24107","24108","24109"],"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1988","bibliographicIssueDateType":"Issued"},"bibliographicPageEnd":"31","bibliographicPageStart":"25","bibliographicVolumeNumber":"23","bibliographic_titles":[{"bibliographic_title":"Tumor Research"},{"bibliographic_title":"Tumor Research","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The long-term results of transcatheter arterial chemoembolization (LP-TAE) for unresectable hepatocellular carcinoma (HCC) were evaluated in comparison with that of transcatheter arterial chemoinfusion (LP-TAI) and systemic chemotherapy. The cumulative survival rate in 29 patients who received LP-TAE at one-year, two-years and three-years were 70.9%, 54.0% and 25.2%, respectively. In contrast, the cumulative survival rate at one-year in patients who received LP-TAI was 20.6% and those who received systemic chemotherapy was 5.6%. The cumulative survival rate for LP-TAE was significantly higher than those for LP-TAI and systemic chemotherapy (p<0.001). The factor that affected the survival rate for LP-TAE was the size of the tumor. Patients with HCC of less than 5cm in diameter lived significantly longer than those with HCC of more than 5cm in diameter (p<0.05).","subitem_description_type":"Abstract"}]},"item_7_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.15114/tr.23.25","subitem_identifier_reg_type":"JaLC"}]},"item_7_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Sapporo Medical University"}]},"item_7_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0041-4093","subitem_source_identifier_type":"ISSN"}]},"item_7_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Suga, Mitsuo"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kodama, Toshinori"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Arima, Kazuhiro"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sakamoto, Hiroshi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Ohe, Yasuo"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Sakamoto, Shin-ichi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Yachi, Akira"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-07-31"}],"displaytype":"detail","filename":"n004140932325.pdf","filesize":[{"value":"265.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"n004140932325.pdf","url":"https://sapmed.repo.nii.ac.jp/record/14293/files/n004140932325.pdf"},"version_id":"2f9bab01-2359-4b2d-bf82-89028ca89b2f"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Transcatheter arterial embolization (TAE)","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Lipiodol","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"LP-TAE","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Hepatocellular carcinoma","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Evaluation of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Evaluation of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma","subitem_title_language":"en"}]},"item_type_id":"7","owner":"15","path":["1716"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-07-31"},"publish_date":"2019-07-31","publish_status":"0","recid":"14293","relation_version_is_last":true,"title":["Evaluation of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma"],"weko_creator_id":"15","weko_shared_id":-1},"updated":"2023-12-13T02:47:01.536831+00:00"}